|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004147,
umls-concept:C0008976,
umls-concept:C0020538,
umls-concept:C0126174,
umls-concept:C0149721,
umls-concept:C0301630,
umls-concept:C0376558,
umls-concept:C0684321,
umls-concept:C0857121,
umls-concept:C1522684,
umls-concept:C1707455,
umls-concept:C1948041,
umls-concept:C2349179
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2004-9-14
|
|
pubmed:abstractText |
An echocardiographic substudy of the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial was designed to test the ability of losartan to reduce left ventricular (LV) mass more than atenolol.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
14
|
|
pubmed:volume |
110
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1456-62
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15326072-Adrenergic beta-Antagonists,
pubmed-meshheading:15326072-Aged,
pubmed-meshheading:15326072-Aged, 80 and over,
pubmed-meshheading:15326072-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:15326072-Antihypertensive Agents,
pubmed-meshheading:15326072-Atenolol,
pubmed-meshheading:15326072-Blood Pressure,
pubmed-meshheading:15326072-Double-Blind Method,
pubmed-meshheading:15326072-Female,
pubmed-meshheading:15326072-Follow-Up Studies,
pubmed-meshheading:15326072-Heart Rate,
pubmed-meshheading:15326072-Heart Ventricles,
pubmed-meshheading:15326072-Humans,
pubmed-meshheading:15326072-Hypertension,
pubmed-meshheading:15326072-Hypertrophy, Left Ventricular,
pubmed-meshheading:15326072-Losartan,
pubmed-meshheading:15326072-Male,
pubmed-meshheading:15326072-Middle Aged,
pubmed-meshheading:15326072-Organ Size,
pubmed-meshheading:15326072-Prospective Studies,
pubmed-meshheading:15326072-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
|
|
pubmed:affiliation |
Cornell Medical Center, 525 E 68th St, New York, NY 10021, USA. rbdevere@med.cornell.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
